Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Clinical trial NCT01363297 · COMPLETED

Trial details

NCT number: NCT01363297
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphocytic Leukemia

Start date: 2011-08-01
Primary completion: 2014-08-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.